From the bronze age to the Industrial Revolution and beyond, the discovery and development of new materials has been a ...

In its latest research paper, Google DeepMind introduced the concept of “Mind Evolution,” a technique that optimizes responses of large language models (LLMs) for planning and reasoning tasks.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

Future of AI and science discussed by Google DeepMind CEO While the potential benefits of AI in science have been spoken about, the CEO of Google DeepMind also addressed the potential timeline of ...

Your guide to what the 2024 US election means for Washington and the world Donald Trump relished the thought that his return to the White House would give him the power to take down the “deep ...

Researchers from Google DeepMind, UC San Diego, and the University of Alberta introduced Mind Evolution, an evolutionary search strategy designed to enhance inference-time computation for LLMs. Unlike ...

A clutch of new customisation and configuration options were added to Refine, a GTK4/libadwaita app in the vein of GNOME Tweaks (but better), over the weekend. Refine is compelling due to its goal of ...

(Bloomberg) — Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. The potential of ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer. “We’ll ...

Update: The story was updated with Isomorphic declining to comment. Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg ...

Jeff Dean, chief scientist of Google DeepMind, stated: The model's design leverages extended computation during inference to improve reasoning outcomes. And Logan Kilpatrick, AI Studio’s product ...